INTRODUCTION
Tuberculosis, or TB, is an infectious bacterial disease caused by Mycobacterium tuberculosis, which most commonly affects the lungs.
It is transmitted from person to person via droplets from the throat and lungs of people with the active respiratory disease.
In healthy people, infection with Mycobacterium tuberculosis often causes no symptoms, since the person's immune system acts to “wall off” the bacteria. The symptoms of active TB of the lung are coughing, sometimes with sputum or blood, chest pains, weakness, weight loss, fever and night sweats. Tuberculosis is treatable with a six-month course of antibiotics.
Symptoms
Signs
of
TB in the lungs may include
- A bad cough that lasts 3 weeks or longer
- Weight loss
- Coughing up blood or mucus
- Weakness or fatigue
- Fever and chills
- Night sweats
- have chest pain when you cough
- Excessive sweating, especially at night
The following people are at higher risk for active TB:
- · Elderly
- · Infants
- · People with weakened immune systems, for example due to AIDS, chemotherapy, diabetes, or certain medications
- · Are in frequent contact with people who have TB
- · Have poor nutrition
- · Live in crowded or unsanitary living conditions
- · Increase in HIV infections
- · Increase in number of homeless people (poor environment and nutrition)
- · The appearance of drug-resistant strains of TB
Transmission
In the lung, the organism is taken
up by alveolar macrophages and carried to lymph nodes, from where
it may spread to multiple organs. Two to eight weeks after infection, cell
mediated immunity (CMI) and hypersensitivity (DTH) develop leading to the
characteristic reaction to the tuberculin test and, in immunocompetent
individuals, containment of infection. Inflammatory immune responses eventually
result in lung damage.
How
is TB treated?
In many countries, vaccination
against TB is routinely practised. The Bacillus Calmette-Guerin (BCG)
vaccine is a live, attenuated strain of Mycobacterium bovis which
was introduced in 1922. However, the true efficacy of BCG is unknown. Early
clinical trials in Europe showed up to 80% protection, but more recent trials
in India and Africa showed little value.
The first effective treatment for TB
was developed in the 1940s - streptomycin.
Online tutorial: Domagk, Fleming, Waksman & the Third Man
Online tutorial: Domagk, Fleming, Waksman & the Third Man
TB is currently treated by means of
combination therapy, using cocktails of 3-4 drugs with different properties:
- Antibacterial activity: e.g. isoniazid, rifampin, streptomycin
- Inhibiting the development of resistance: e.g. isoniazid, rifampin, ethambutol
What are Mycobacteria?
Tuberculosis complex organisms are:
- Obligate aerobes growing most successfully in tissues with a high oxygen content, such as the lungs.
- Facultative intracellular pathogens usually infecting mononuclear phagocytes (e.g. macrophages).
- Slow-growing with a generation time of 12 to 18 hours (c.f. 20-30 minutes for Escherichia coli).
- Hydrophobic with a high lipid content in the cell wall. Because the cells are hydrophobic and tend to clump together, they are impermeable to the usual stains, e.g. Gram's stain.
- Known as "acid-fast bacilli" because of their lipid-rich cell walls, which are relatively impermeable to various basic dyes unless the dyes are combined with phenol. Once stained, the cells resist decolorization with acidified organic solvents and are therefore called "acid-fast". (Other bacteria which also contain mycolic acids, such as Nocardia, can also exhibit this feature.)
Signs
and tests
The doctor or nurse will perform a
physical exam. This may show:
- Clubbing of the fingers or toes (in people with advanced disease)
- Swollen or tender lymph nodes in the neck or other areas
- Fluid around a lung (pleural effusion)
- Unusual breath sounds (crackles)
Tests may include:
- Biopsy of the affected tissue (rare)
- Bronchoscopy
- Chest CT scan
- Chest x-ray
- Interferon-gamma blood test such as the QFT-Gold test to test for TB infection
- Sputum examination and cultures
- Thoracentesis
- Tuberculin skin test (also called a PPD tests)
- · Pulmonary TB can cause permanent lung damage if not treated early.
- · Medicines used to treat TB may cause side effects, including liver problems. Other side effects include:
- · Changes in vision
- · Orange- or brown-colored tears and urine
- · Rash
Disseminated
tuberculosis (TB) is a contagious bacterial infection that has spread from the
lungs to other parts of the body through the blood or lymph
system.
Indications
he disease may also alter the results of the
following tests:
·
Complete blood
count (CBC)
·
Peripheral blood
smear
·
Blood calcium
level
Complications of disseminated TB
Complications of disseminated TB can
include:
- Adult respiratory distress syndrome (ARDS)
- Liver inflammation
- Lung failure
- Relapse of the disease
Medicines used to treat TB may cause
side effects, including liver problems. Other side effects include:
- Changes in vision
- Orange- or brown-colored tears and urine
- Rash
A vision test may be done before
treatment so your doctor can monitor any changes in your eyes' health over
time.
The disease may also alter the results of the
following tests:- · Complete blood count (CBC)
- · Peripheral blood smear
- · Blood calcium level
Treatment
The goal of treatment is to cure the
infection with drugs that fight the TB bacteria. Treatment of active pulmonary
TB will always involve a combination of many drugs (usually four drugs). All of
the drugs are continued until lab tests show which medicines work best.
The most commonly used drugs
include:
Other drugs that may be used to
treat TB include:
- Amikacin
- Ethionamide
- Moxifloxacin
- Para-aminosalicylic acid
- Streptomycin
You may need to take many different
pills at different times of the day for 6 months or longer. It is very
important that you take the pills the way your health care provider instructed.
When people do not take their TB
medications as recommended, the infection may become much more difficult to
treat. The TB bacteria may become resistant to treatment, and sometimes, the
drugs no longer help treat the infection.
When there is a concern that a
patient may not take all the medication as directed, a health care provider may
need to watch the person take the prescribed drugs. This is called directly
observed therapy. In this case, drugs may be given 2 or 3 times per week, as
prescribed by a doctor.
You may need to stay at home or be
admitted to a hospital for 2 - 4 weeks to avoid spreading the disease to others
until you are no longer contagious.
Your doctor or nurse is required by
law to report your TB illness to the local health department. Your health care
team will be sure that you receive the best care for your TB.
Introduction
Untreated tuberculosis (TB) disease
represents a greater hazard to a pregnant woman and her fetus than does its
treatment. Treatment of pregnant women should be initiated whenever the
probability of TB is moderate to high. Infants born to women with untreated TB
may be of lower birth weight than those born to women without TB and, in rare
circumstances the infant may be born with TB. Although the drugs used in the
initial treatment regimen for TB cross the placenta, they do not appear to have
harmful effects on the fetus.
The tuberculin skin test is
considered both valid and safe to use throughout pregnancy. The TB blood test
is safe to use during pregnancy, but has not been evaluated for diagnosing M.
tuberculosis infection in pregnant women. Other tests are needed to show if
a person has TB disease.
Treatment
Latent TB Infection (LTBI) – Isoniazid (INH)
( administered either daily or twice weekly for 9 months is the standard regimen for the treatment of LTBI in pregnant women). Women taking INH should also take pyridoxine (vitamin B6) supplementation.Caution: The 12-dose regimen of INH and Rifapentine (RPT) is NOT RECOMMENDED for pregnant women or women expecting to be pregnant within the next 3 months.
( administered either daily or twice weekly for 9 months is the standard regimen for the treatment of LTBI in pregnant women). Women taking INH should also take pyridoxine (vitamin B6) supplementation.Caution: The 12-dose regimen of INH and Rifapentine (RPT) is NOT RECOMMENDED for pregnant women or women expecting to be pregnant within the next 3 months.
TB Disease –
Treatment regimen :
The preferred initial treatment regimen is
Treatment regimen :
The preferred initial treatment regimen is
- INH,
- rifampin (RIF),
- ethambutol (EMB) (daily for 2 months)
followed by INH and RIF daily, or twice
weekly for
7 months (for a total of 9 months of treatment).
Streptomycin should
not be used because it has been
shown to have harmful effects on the fetus. In
most
cases, pyrazinamide (PZA) is not recommended to be
used because its effect
on the fetus is unknown.
HIV Infection :
. TB treatment regimens for HIV-infected pregnant women should include a rifamycin. Although the routine use of PZA during pregnancy is not recommended in the United States, the benefits of a TB treatment regimen that includes PZA for HIV-infected pregnant women may outweigh the undetermined potential risks to the fetus.
. TB treatment regimens for HIV-infected pregnant women should include a rifamycin. Although the routine use of PZA during pregnancy is not recommended in the United States, the benefits of a TB treatment regimen that includes PZA for HIV-infected pregnant women may outweigh the undetermined potential risks to the fetus.
Contraindications
The following antituberculosis drugs
are contraindicated in pregnant women:
- Streptomycin
- Kanamycin
- Amikacin
- Capreomycin
- Fluoroquinolones
Women who are being treated for
drug-resistant TB should receive counseling concerning the risk to the fetus
because of the known and unknown risks of second-line antituberculosis drugs.
Breastfeeding
- Breastfeeding should not be discouraged for women being treated with the first-line antituberculosis drugs( because the concentrations of these drugs in breast milk are too small to produce toxicity in the nursing newborn).
- For the same reason, drugs in breast milk are not an effective treatment for TB disease or LTBI in a nursing infant.
- Breastfeeding women taking INH should also take pyridoxine (vitamin B6) supplementation.
Patient advice:
- Advice the patient to sit in open enviornment.
- sit in area where there is necessary light
- avoid siting in dark room as it gives strength to bacteria in growing ,making colonies.
- Mantain dietry intake eat more n more apples,pomegranate,beet root.
No comments:
Post a Comment